Search

everythinglearnresearchcommunity

for

Search:↓

Start with 2.5 mg/mL triamcinolone acetonide for scalp alopecia areata and increase if needed.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Serial trichoscopy is more reliable than the modified hair pull test for tracking alopecia areata.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

The Hair660™ light therapy device effectively and safely improves hair density in people with androgenetic alopecia.

Using a special laser and skin medication together successfully cleared a skin condition in a pregnant woman.

Allethrin caused harmful effects and organ damage in rats, worsening with higher doses and longer exposure.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Motion-graphic videos improve patient understanding more than verbal explanations for platelet-rich plasma therapy.

Testosterone and finasteride improve muscle strength and size after spinal cord injury.

Baricitinib was effective in treating alopecia areata in two major trials.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

CONSORT improves trial reporting but doesn't assess bias.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

The laser treatment improved hair appearance and was safe and well-received by patients.

Hyperbaric oxygen therapy shows promise for multiple sclerosis, but skepticism and funding issues limit tech use in clinics, and outdated single-drug cancer treatments may cause unnecessary side effects.

Low copper levels might cause premature graying of hair.

Omalizumab may cause hair loss.

Cyclosporin extends hair growth in mice, but high-dose corticosteroids block this effect.

CD4+ lymphocytopenia can occur in patients with systemic lupus erythematosus.

Chronic inflammation can cause cancer by making stem cells divide and mutate.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.